Camptothecin and Podophyllotoxin Derivatives: Inhibitors of Topoisomerase I and II – Mechanisms of Action, Pharmacokinetics and Toxicity Profile

Author： Hartmann Jörg T.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.29, Iss.3, 2006-01, pp. : 209-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel camptothecin derivatives as topoisomerase I inhibitors

By Basili Serena   Moro Stefano  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 5, 2009-05 ,pp. : 555-574

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of the topoisomerase II inhibitors

By Seiter Karen  

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 219-234

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of the topoisomerase I inhibitors

By Seiter Karen  

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 45-53

Informa Healthcare

Access to resources Recommend Favorite

Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 305-320

Bentham Science Publishers

Access to resources Recommend Favorite

New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4389-4409

Bentham Science Publishers

Access to resources Recommend Favorite